CHDHF yields 1996.01% · PFE yields 6.13%● Live data
📍 CHDHF pulled ahead of the other in Year 1
Combined, CHDHF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CHDHF + PFE for your $10,000?
Ev Dynamics (Holdings) Limited, an investment holding company, manufactures electric vehicles in the Philippines, Spain, Germany, and Mexico. It operates in three segments: Development of Electric Vehicles, Mining, and Metals and Minerals Trading. The company manufactures in electric buses, electric power and control systems, and other buses; and markets and sells vehicle components. It also owns the Glauberite Mine located in the Guangxi Zhuang Autonomous Region, the People's Republic of China. In addition, the company is involved in the manufacturing and trading of motor vehicles and batteries; trading of metals and minerals; mining and sale of mineral resources; and development and marketing of new energy technology and products. Further, it provides management and computer maintenance services; trades in computer hardware and software; and develops software. The company was formerly known as China Dynamics (Holdings) Limited and changed its name to Ev Dynamics (Holdings) Limited in July 2021. Ev Dynamics (Holdings) Limited was incorporated in 1996 and is headquartered in Wan Chai, Hong Kong.
Full CHDHF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.